Association between serum 25(OH)D and death from prostate cancer - PubMed (original) (raw)
Association between serum 25(OH)D and death from prostate cancer
S Tretli et al. Br J Cancer. 2009.
Abstract
Based on observations that for certain cancers, mortality varies according to sun exposure, vitamin D has been proposed to influence on disease progression. This study aims to investigate whether serum levels of 25(OH)D are associated with prognosis in patients with prostate cancer. In total, 160 patients with a serum sample in the JANUS serum bank were included. For 123 patients a pre-treatment serum sample was taken, whereas 37 of the patients had received hormone therapy prior to the blood collection. The serum level of 25(OH)D was classified as low (<50 nmol l(-1)), medium (50-80 nmol l(-1)) or high (>80 nmol l(-1)). A Cox proportional hazard regression model was used to assess the association between serum 25(OH)D and cancer mortality. During follow-up, 61 deaths occurred, of whom 52 died of prostate cancer. The median time of follow-up was 44.0 months (range, 1.2-154.6). Serum 25(OH)D at medium or high levels were significantly related to better prognosis (RR 0.33; 95% CI 0.14-0.77, RR 0.16; 95% CI 0.05-0.43) compared with the low level. Analysis restricted to patients receiving hormone therapy gave a stronger association. The serum level of 25(OH)D may be involved in disease progression and is a potential marker of prognosis in patients with prostate cancer.
Similar articles
- Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.
Holt SK, Kolb S, Fu R, Horst R, Feng Z, Stanford JL. Holt SK, et al. Cancer Epidemiol. 2013 Oct;37(5):666-70. doi: 10.1016/j.canep.2013.07.005. Epub 2013 Aug 20. Cancer Epidemiol. 2013. PMID: 23972671 Free PMC article. - Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer.
Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E. Fang F, et al. PLoS One. 2011 Apr 6;6(4):e18625. doi: 10.1371/journal.pone.0018625. PLoS One. 2011. PMID: 21494639 Free PMC article. - Long Term Association between Serum 25-Hydroxyvitamin D and Mortality in a Cohort of 4379 Men.
Meyer HE, Støer NC, Samuelsen SO, Blomhoff R, Robsahm TE, Brustad M, Giovannucci EL, Bjørge T. Meyer HE, et al. PLoS One. 2016 Mar 17;11(3):e0151441. doi: 10.1371/journal.pone.0151441. eCollection 2016. PLoS One. 2016. PMID: 26986958 Free PMC article. - Association between serum concentration of vitamin D and 1-year mortality in stroke patients.
Daubail B, Jacquin A, Guilland JC, Khoumri C, Aboa-Eboulé C, Giroud M, Béjot Y. Daubail B, et al. Cerebrovasc Dis. 2014;37(5):364-7. doi: 10.1159/000362534. Epub 2014 Jun 21. Cerebrovasc Dis. 2014. PMID: 24970287 - Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study.
Schöttker B, Haug U, Schomburg L, Köhrle J, Perna L, Müller H, Holleczek B, Brenner H. Schöttker B, et al. Am J Clin Nutr. 2013 Apr;97(4):782-93. doi: 10.3945/ajcn.112.047712. Epub 2013 Feb 27. Am J Clin Nutr. 2013. PMID: 23446902
Cited by
- Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications.
Body JJ, Bergmann P, Boonen S, Devogelaer JP, Gielen E, Goemaere S, Kaufman JM, Rozenberg S, Reginster JY. Body JJ, et al. Osteoporos Int. 2012 Feb;23 Suppl 1(Suppl 1):S1-23. doi: 10.1007/s00198-011-1891-8. Epub 2012 Feb 4. Osteoporos Int. 2012. PMID: 22311111 Free PMC article. - Vitamin D and Hypoxia: Points of Interplay in Cancer.
Gkotinakou IM, Mylonis I, Tsakalof A. Gkotinakou IM, et al. Cancers (Basel). 2022 Mar 31;14(7):1791. doi: 10.3390/cancers14071791. Cancers (Basel). 2022. PMID: 35406562 Free PMC article. Review. - Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.
Vashi PG, Lammersfeld CA, Braun DP, Gupta D. Vashi PG, et al. Nutr J. 2011 May 16;10:51. doi: 10.1186/1475-2891-10-51. Nutr J. 2011. PMID: 21575232 Free PMC article. - Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma.
Cho M, Peddi PF, Ding K, Chen L, Thomas D, Wang J, Lockhart AC, Tan B, Wang-Gillam A. Cho M, et al. J Transl Med. 2013 Sep 8;11:206. doi: 10.1186/1479-5876-11-206. J Transl Med. 2013. PMID: 24011168 Free PMC article. - Prediagnostic Serum 25-Hydroxyvitamin D and Mortality Among Bladder Cancer Patients in the Janus Serum Bank Cohort.
Hektoen HH, Gislefoss RE, Stenehjem JS, Langseth H, Axcrona K, Mondul AM, Robsahm TE, Andreassen BK. Hektoen HH, et al. Clin Epidemiol. 2021 Sep 14;13:801-811. doi: 10.2147/CLEP.S319620. eCollection 2021. Clin Epidemiol. 2021. PMID: 34548821 Free PMC article.
References
- Al-Delaimy WK, jansen EHJM, Peeters PHM, Van Der Laan JD, Van Noord PAH, Boshuizen HC, Van Der Schouw YT, Jenab M, Ferarri P, Bueno-de-Mesquita HB (2006) Reliability of biomarkers of iron status, blood lipide, oxidative stress, vitamin D, C-reactive protein and fructosamine in two Dutch cohorts. Biomarkers 11: 370–382 - PubMed
- Apperly FL (1941) The relation of solar radiation to cancer mortality in North America. Cancer Res 1: 191–195 - PubMed
- Berwick M, Armstrong BK, Ben-Porat L, Kricker A, Eberle C, Barnhill R (2005) Sun exposure and mortality from melanoma. J Natl Cancer Inst 97: 195–199 - PubMed
- Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Watson-Hughes B (2006) Estimation of optimal serum concentration of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin 84: 18–28 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical